Респираторная медицина. Руководство (в 2-х томах)
Шрифт:
132.Sanner BM, Konermann M, Tepel M, et al: Platelet function in patients with obstructive sleep apnoea syndrome. Eur Respir J 16:648-652, 2000.
133.Bokinsky G, Miller M, Ault K, et al: Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure: A preliminary investigation. Chest 108:625-630, 1995.
134.Nobili L, Schiavi G, Bozano E, et al: Morning increase in whole blood viscosity in obstructive sleep apnea syndrome. Clin Hemorheol Microcirc 22:21-27, 2000.
135.Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al: Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105:2462-2464, 2002.
136.Schulz R, Mahmoudi S, Hattar K, et al: Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162:566-570, 2000.
137.Dyugovskaya L, Lavie P, Lavie L: Increased adhesion molecule expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165:934-939, 2002.
138.Lavie L, Kraiczi H, Hefetz A, et al: Plasma vascular endothelial growth factor in sleep apnea syndrome: Effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med 165:1624-1628, 2002.
139.Ip MS, Lam B, Ng MMT, et al: Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670-676, 2002.
140.Punjabi NM, Sorkin JD, Karzel LI, et al: Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165:677-682, 2002.
141.Chin K, Shimizu K, Nakamura T, et al: Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100:706-712, 1999.
142.Harsch IA, Schahin SP, Radespiel-Troger M, et al: Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169:156-162, 2004.
143.Bradley TD, Rutherford R, Grossman RF, et al: Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis 131:835-839, 1985.
144.Weitzenblum E, Krieger J, Apprill M, et al: Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 138:345-349, 1988.
145.Bradley TD, Rutherford R, Lue F, et al: Role of diffuse airway obstruction in the hypercapnia of obstructive sleep apnea. Am Rev Respir Dis 134:920-924, 1986.
146.Garay SM, Rapoport D, Sorkin B, et al: Regulation of ventilation in the obstructive sleep apnea syndrome. Am Rev Respir Dis 124:451-457, 1981.
147.Lopata M, Onal E: Mass loading, sleep apnea, and the pathogenesis of obesity hypoventilation. Am Rev Respir Dis 126:640-645, 1982.
148.. Loube DI, Strohl KP: Obstructive sleep apnea syndrome: Screening and diagnosis. In McNicholas WT, Phillipson EA (eds): Breathing Disorders in Sleep. London: WB Saunders, 2002, pp 86-102.
149.. Whittle AT, Finch SP, Mortimore IL, et al: Use of home sleep studies for diagnosis of the sleep apnoea/hypopnoea syndrome. Thorax 52:1068-1073, 1997.
150.. Hoffstein V: Is snoring dangerous to your health? Sleep 19:506-516, 1996.
151.. Braver HM, Block AJ, Perri MG: Treatment for snoring: Combined weight loss, sleeping on the side, and nasal spray. Chest 107:1283-1288, 1995.
152.. American Thoracic Society: Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. Am J Respir Crit Care Med 150:1738-1745, 1994.
153.. L'evy P, P'epin JL: Management options in obstructive sleep apnea syndrome. In McNicholas WT, Phillipson EA (eds): Breathing Disorders in Sleep. London: WB Saunders, 2002, pp 105-115.
154.. Hoffstein V: Clinical significance and management of snoring without obstructive sleep apnea syndrome. In McNicholas WT, Phillipson EA (eds): Breathing Disorders in Sleep. London: WB Saunders, 2002, pp 164-178.
155.. O'Sullivan RA, Hillman DR, Mateljan R, et al: Mandibular advancement splint: An appliance to treat snoring and obstructive sleep apnea. Am J Respir Crit Care Med 151:194-198, 1995.
156.. Ferguson KA, Ono T, Lowe A, et al: A randomized cross-over trial of an oral appliance vs. nasal continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. Chest 109:1269-1275, 1996.
157.. Stradling JR, Negus TW, Smith D, et al: Mandibular advancement devices for the control of snoring. Eur Respir J 11:447-450, 1998.
158.. Engleman HE, Kingshott RN, Wraith PK, et al: Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 159:461-467, 1999.
159.. Fujita S, Conway W, Zorick F, et al: Surgical correction of anatomic abnormalities in obstructive sleep apnea syndrome: Uvulopalatopharyngoplasty. Otolaryngol Head Neck Surg 89:923-934, 1981.
160.. Kamami YV: Laser CO2 for snoring: Preliminary results. Acta Otorhinolaryngol Belg 44:451-456, 1990.
161.. Schmidt-Nowara WW, Meade TE, Hays MB: Treatment of snoring and obstructive sleep apnea with a dental orthosis. Chest 99:1378-1385, 1991.
162.. Ng AT, Gotsopoulos H, Qian J, Cistulli PA: Effect of oral appliance therapy on upper airway collapsibility in obstructive sleep apnea. Am J Respir Crit Care Med 168:238-241, 2003.
163. Sher AE, Schechtman KB, Piccirillo JF: The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome. Sleep 19:156-177, 1996.